aureus were examined by SEM observation (SU3500, HITACHI, Japan)
If this drug truly improves liver inflammation and fibrosis markers while driving weight loss, thats where it could carve out a real niche. Kristin Kuminski, a registered dietitian nutritionist with The RX Index, who wasnt involved in the trial, called the results significant, placing survodutide at a similar level of efficacy to tirzepatide
Clinical studies have not led to FDA approval for any indication
In a randomized placebo-controlled pilot study, researchers examined whether adding phentermine to patients already on liraglutide (a GLP-1 agonist) for one year would produce additional weight loss
Proceed to prior authorization with your provider
Patients can ask questions and report any side effects to their assigned healthcare provider as needed